IPP Bureau
DKSH and Biolin Scientific extend partnership in the APAC region
By IPP Bureau - August 09, 2023
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Altana acquires ultrasound metrology company Imaginant
By IPP Bureau - August 09, 2023
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
By IPP Bureau - August 09, 2023
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Lonza launches nebula absorbance reader for streamlined Endotoxin and Pyrogen testing
By IPP Bureau - August 09, 2023
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Mandaviya addresses BRICS Health Minister’s meeting
By IPP Bureau - August 09, 2023
Reiterates India’s commitment to the BRICS TB Research Network Initiative
USFDA completes PAD E inspection of Marksans' Goa facility
By IPP Bureau - August 09, 2023
The inspection was conducted at its Goa, Vema manufacturing facility
Lupin receives USFDA approval for fluocinolone acetonide body oil
By IPP Bureau - August 09, 2023
Fluocinolone Acetonide Oil (RLD Derma-Smoothe/FS®) had estimated annual sales of USD 10 million in the U.S. (IQVIA MAT June 2023)
Brenntag partners with Qualifyze to enhance pharma audit offering
By IPP Bureau - August 09, 2023
Qualifyze specializes in Good Practice audits (GxP) audits and covers a wide range of areas, including excipients, starting materials, packaging, sustainability
Govt. passes National Dental Commission Bill, 2023
By IPP Bureau - August 09, 2023
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Parliament passes National Nursing and Midwifery Commission (NNMC) Bill, 2023
By IPP Bureau - August 09, 2023
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
KIMS posts Q1 FY24 consolidated PAT at Rs. 80.81 Cr
By IPP Bureau - August 08, 2023
KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023
Torrent Pharmaceuticals posts Q1 FY 24 consolidated PAT at Rs. 378 Cr
By IPP Bureau - August 08, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Gland Pharma posts Q1 FY24 consolidated PAT at Rs. 194.10 Cr
By IPP Bureau - August 08, 2023
Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023
